Sign in
CompletedNo phase

Microcirculation Properties of Albumin for Fluid Resuscitation in Septic Shock

Key facts

Who runs it
Rachael Cusack
Where
Ireland1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
100 people enrolled
Started
1 Sept 2021
Ended
1 Dec 2023
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • 20% Albumin
  • Crystalloid
Record updated
26 October 2024

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Sepsis; suspected source of infection, tachycardia, tachypneic, hyperlactatemia, hypotensive requiring vasopressors, febrile >38.5degrees Celsius
  • Fluid responsive; pulse pressure variability >10% or passive leg raise positive

Who cannot take part

  • Heart Failure, cardiogenic shock, recent MI
  • Receiving regular albumin 20%
  • Fluid overloaded; pulmonary oedema, significant peripheral oedema

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The sublingual microcirculation is impaired in sepsis and septic shock. Sidestream dark field imaging technology has been developed into a clinical tool to help the clinician assess the microcirculation at the bedside. The ideal resuscitation fluid has not been identified. The investigators aim to use this new bedside technology to establish the microcirculation properties of two popular resuscitation fluids.

The 2 groups in the trial

  • Interventional 20% AlbuminTreatment being tested

    Septic patients requiring a fluid bolus randomised to receive 100ml 20% albumin as boluses until they are stable or no longer require fluid resuscitation.

    Treatment: 20% Albumin

  • Control CrystalloidExisting treatment, for comparison

    Septic patients requiring a fluid bolus randomised to receive 250ml boluses of crystalloid fluid until they no longer require fluid resuscitation.

    Treatment: Crystalloid

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Effect of Fluid Resuscitation with 20% Albumin Versus Crystalloid on the Microcirculation of Patients with Sepsis
Publications
Record updated
26 October 2024